• BMS looks to RNA splicing to boost immunotherapies pharmaphorum
    December 19, 2018
    Bristol-Myers Squibb’s quest to claim dominance in the immunotherapy space continues through a new collaboration with Eisai and its US-based precision medicine subsidiary H3 Biomedicine to.....
PharmaSources Customer Service